Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)

NCT00468312 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

429

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: Mometasone furoate nasal spray
DRUG: Placebo

Sponsor

Organon and Co